We are live on ! Find out more
ONCT

Oncternal Therapeutics, Inc. Common Stock
ONCT

Delisted

ONCT was delisted on the 2nd of December, 2024.

Back to rankings

4 hedge funds and large institutions have $10 invested in Oncternal Therapeutics, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% less funds holding

Funds holding: 23 → 4 (-19)

95% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 20

100% less capital invested

Capital invested by funds: $471K → $10 (-$471K)

Holders
4
Holders Change
-19
Holders Change %
-82.61%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
20
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$185K
2
Millennium Management
Millennium Management
New York
-$80.8K
3
BlackRock
BlackRock
New York
-$52.4K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$34.2K
5
PPW
Pasadena Private Wealth
California
-$33K
Name Holding Trade Value Shares
Change 		Change in
Stake
SPIA
1
Steward Partners Investment Advisory
New York
$8 – – –
NRG
2
Nemes Rush Group
Michigan
$2 – – –
Vanguard Group
3
Vanguard Group
Pennsylvania
– -$185K -139,884 Closed
Millennium Management
4
Millennium Management
New York
– -$80.8K -61,205 Closed
BlackRock
5
BlackRock
New York
– -$52.4K -39,706 Closed
Geode Capital Management
6
Geode Capital Management
Massachusetts
– -$34.2K -25,879 Closed
PPW
7
Pasadena Private Wealth
California
– -$33K -25,000 Closed
Renaissance Technologies
8
Renaissance Technologies
New York
– -$23.6K -17,905 Closed
Morgan Stanley
9
Morgan Stanley
New York
– -$18.7K -14,152 Closed
QPW
10
Quantum Private Wealth
Florida
– -$17.4K -13,187 Closed
VF
11
Virtu Financial
New York
– -$16K -12,276 Closed
TRCT
12
Tower Research Capital (TRC)
New York
– -$3.73K -2,822 Closed
UBS Group
13
UBS Group
Switzerland
– -$1.61K -1,221 Closed
JP Morgan Chase
14
JP Morgan Chase
New York
– -$1.47K -1,111 Closed
Wells Fargo
15
Wells Fargo
California
– -$539 -408 Closed
NSIM
16
North Star Investment Management
Illinois
– -$330 -250 Closed
BNP Paribas Financial Markets
17
BNP Paribas Financial Markets
France
– -$240 -182 Closed
Osaic Holdings
18
Osaic Holdings
Arizona
– -$198 -150 Closed
Bank of America
19
Bank of America
North Carolina
– -$29 -22 Closed
TC
20
Truvestments Capital
Florida
– -$29 -22 Closed
LC
21
Lindbrook Capital
California
– -$20 -15 Closed
DB
22
Danske Bank
Denmark
– -$1 -1 Closed
PAM
23
Parvin Asset Management
South Dakota
– +$51 +40 New

ONCT Hedge Fund Activity: Q4 2024 in Review

4 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Oncternal Therapeutics, Inc. Common Stock (ONCT) for Q4 2024, worth a combined $10 — down 100% from $471K a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of ONCT and 1 opened new positions — a net loss of 19 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $185K sold.

  • 4 institutional investors held Oncternal Therapeutics, Inc. Common Stock (ONCT) as of Q4 2024, down from 23 in Q3 2024.
  • Funds reported $10 of Oncternal Therapeutics, Inc. Common Stock stock for Q4 2024, down 100% quarter-over-quarter.
  • 1 fund opened new Oncternal Therapeutics, Inc. Common Stock positions in Q4 2024 and 20 closed out, a net change of -19 holders.
  • The largest Oncternal Therapeutics, Inc. Common Stock seller in Q4 2024 was Vanguard Group, an estimated $185K sold.

Based on aggregated 13F filings for Q4 2024.